In May 2024, Knight entered into an agreement with Ironshore Pharmaceuticals & Development, Inc., a wholly owned subsidiary of Ironshore Therapeutics, Inc. (now part of Collegium Pharmaceutical, Inc.; ...
Treatment About half of the students with attention deficit disorders Disability Services assists are still taking medication, Schrot said. That’s not unusual, said Shapiro. Some adolescents and young ...
Introduction Attention-deficit/hyperactivity disorder (ADHD) is one of the most prevalent neurodevelopmental disorders and is a persistent pattern of inattention and ...
Purpose: The pharmacology, pharmacokinetics, clinical efficacy, safety, drug interactions, dosage and administration, and place in therapy of atomoxetine in the treatment of attention-deficit ...
Knight Therapeutics Inc. ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that Health Canada has approved JORNAY PMtm, an extended-release formulation of ...
Recently, Bollywood actress Alia Bhatt opened up about being diagnosed with ADHD. This brought attention to a prevalent but not much talked about neurological ...